a basis for diagnosis, family studies have established that HCM is often genetically transmitted in a pattern consistent with autosomal dominant inheritance.2,5-12 Significant variability in the morphological and clinical expression of the disease within a single family demonstrates the pleiotropy that can be associated with a single disease gene.2,7-12 Decreased penetrance in many kindreds is reflected by fewer than the expected number of affected first-degree relatives. Studies using two-dimensional echocardiographic criteria to establish diagnosis have shown that 15-35%, rather than the predicted 50%, of first-degree relatives of the affected individuals have the disease themselves.27-12 Of unrelated patients diagnosed as having HCM, 45% have no affected first-degree relatives.10 These observations have been interpreted to indicate that there is a significant incidence of nonfamilial HCM. 10 Conventional anatomic and biochemical studies have provided no reliable clues to the molecular mechanism of HCM. Phenotypic heterogeneity is clearly reflected by the extreme clinical variability often seen within a single family where one disease allele is segregating.10 In addition to this phenotypic heterogeneity, genetic heterogeneity between families could result from different disease alleles at a single locus or from disease alleles found at different loci.
Linkage analysis using DNA polymorphisms has been very useful in identifying affected loci in genetic diseases. [13] [14] [15] [16] Gene mapping by linkage analysis takes advantage of the behavior of chromosomes in germ cells during meiosis. Two loci close to each other on the same chromosome will usually not sort independently in subsequent generations. Therefore, the process of mapping a gene by linkage analysis is a search, using known polymorphic chromosomal markers, for cosegregation of a marker with the disease. The polymorphisms detected by the markers in our study have been primarily of three types: 1) site polymorphisms, 2) variable number of tandem repeats, and 3) single-strand conformation polymorphisms. The first reflect the presence or loss of a particular restriction site in a unique sequence of DNA. The second reflect allelic variation in the number of tandemly repeated sequences flanked by unique-sequence DNA.17 These polymorphisms may be detected both by standard Southern blot techniques and through the use of polymerase chain reaction (PCR) -amplified products resolved on standard sequencing gels. Variable numbers of tandem repeats are particularly valuable because the large number of possible variants at such a locus increases the probability that the marker will be informative in families in which the disease gene is segregating. 
Methods

Family Characteristics
Families appropriate for these studies were identified by interviewing individual patients followed at the National Institutes of Health (NIH) Cardiology Clinic. We identified five three-generation families that included 10 or more individuals at risk for HCM who were available for diagnostic studies. Approval for these studies was obtained from the National Heart, Lung, and Blood Institute Research Subpanel, and informed consent was given by all individuals who participated. Individuals at risk for HCM were evaluated by history, physical examination, ECG, and echocardiography. Echocardiography
Echocardiographic studies were performed with a Hewlett-Packard (Sonos 500 or Sonos 1000) real-time, pulsed array, 900 ultrasonic scanner with a 2.5-MHz transducer. Real-time studies were recorded at 60 frames per second. Two-dimensional echocardiographic images were obtained in a number of crosssectional planes by use of standard transducer positions. With methods described previously,",2,10 we assessed the distribution of left ventricular hypertrophy primarily in the parasternal short-axis planes, although parasternal long-axis, apical two-and four-chamber views were also used to integrate the information obtained from the short-axis images. In the short-axis plane, the left ventricle was divided into four regions: the anterior and posterior ventricular septa and the anterolateral and posterior left ventricular free walls. Presence and extent of left ventricular hypertrophy in these four regions were evaluated in diastole at the level of the mitral valve and the papillary muscle directly from the television monitor and with aid of calipers. Thicknesses of the anterior ventricular septum and posterior free wall were also assessed quantitatively from the M-mode echocardiogram.
Determination of Disease Status
The diagnosis of HCM was made in all adult individuals in whom the left ventricular wall thickness was >15 mm.22 Two children, aged 3 and 14 years, were also diagnosed as having HCM on the basis of abnormal ECGs, systolic anterior motion of the mitral valve, and left ventricular wall thicknesses of 10 and 12 mm, respectively.22 In no instance was there evidence of aortic valvular stenosis. The medical records of individuals with a history of hypertension were obtained from their personal physicians; in no instance had the blood pressure exceeded 140/95 mm Hg on repeated measurements while on antihypertensive medication over a period of the last 5 years. All recordings were examined by a cardiologist without knowledge of the individual's clinical status or position in the pedigree. Disease status was recorded as affected, normal, or unknown.
DNA Analysis
Each family member was phlebotomized, and DNA was extracted from isolated nuclei of peripheral white cells by procedures described previously. 23 Lymphoblastoid cell lines were established by Epstein-Barr virus transformation of peripheral blood lymphocytes from older individuals, from persons at risk for sudden death, and from those unlikely to be available for future sampling.
Southern blots were performed by standard protocols. After digestion with restriction endonuclease, DNA was electrophoretically separated on agarose gels and was transferred to a nylon membrane (Gelman) with an alkaline24 or ammonium acetate transfer buffer.25 Probes were labeled with random primers,26 and hybridization and washing were conducted by standard methods. The probes 9.1b and EFD122p were isolated subclones of the cosmids YNZ9.127 and EFD122. 28 The clone HHH160 has not been reported previously. LP2, a polymorphism-detecting Single-strand conformation polymorphism analysis of the PCR-amplified fragments derived from the MYOB-16 and MYOB-X3 primers was performed with a modification of the procedure described by Orita et al. 18 Briefly, 1 ,l of a 100-,l reaction was diluted with 9 ,gl of a denaturing solution (95% formamide, 20 mmol/1 EDTA, 0.05% bromphenol blue, and 0.05% xylene cyanol), heated to 80°C, and resolved on 5% polyacrylamide-10% glycerol gels run at 30 W at room temperature or on 5% polyacrylamide gels run at 4°C. The PCR-amplified fragments generated with the MYOB-2124 primers are CA repeats and thus were easily resolved on a standard 8% polyacrylamide sequencing gel run at 60 W for 3 hours.
Linkage and Statistical Analysis
At the outset of our studies, we prospectively assumed a penetrance of 0.8. This was based on several considerations. The first consideration was the body of literature describing a reduced prevalence of echocardiographic-defined HCM in first-degree relatives of patients with familial HCM.2,12,32,33 The second was the known age dependency of echocardiographic findings in HCM as reflected in the observation of decreasing frequency of HCM in successive generations of affected families.31'32 The third was the description of five adult obligate carriers of the HCM gene without echocardiographic evidence of the disease. 6 Population allele frequencies of DNA markers were used in the genetic analysis when possible. 
Clinical Studies
Members of the five families were examined and their phenotypes determined according to criteria described in the "Methods" section. The diagnostic details of all affected and unknown individuals are presented in Tables 2 and 3 Figure 1 depicts 58 direct descendants of a first-cousin consanguineous mating. From this family, 22 individuals were diagnosed as being affected with HCM. In the 20 of these who were diagnosed at the NIH, echocardiographic criteria were used to determine disease status. An additional family member (538), diagnosed elsewhere on the basis of echocardiography and cardiac catheterization, died as a consequence of her disease. One additional individual (518) was diagnosed as being affected, although the ventricular wall maximal thickness was 14 mm. This diagnosis was made despite a history of mild hypertension because there was irregularity in the ventricular wall thickening in the presence of Wolff-Parkinson-White syndrome. The patient also had experienced intermittent chest pain despite the normal appearance of coronary arteries upon catheterization. Twelve individuals were scored as unknown on the basis of inadequate echocardiographic data, an abnormal ECG but a normal echocardiographic study, or unavailability.
Kindred 2003. Figure 1 depicts 11 direct descendants of an affected first-generation family member. All 12 individuals from this family were seen at the NIH. Three had standard echocardiographic evidence of HCM. One was scored as unknown because the ECG was abnormal despite a normal echocardiogram. On echocardiographic study, the first-generation family member exhibited marked left ventricular wall thickness at the level of the midcavity (midcavity obstruction); this morphological pattern was not present in the affected progeny. The three alternative orders and corresponding recombination frequencies were 1) HHH160, L436, L329 (0.13,0.016); 2) HHH160, L329, L436 (0.084,0.08); and 3) L329, HHH160, L436 (0.031, 0.138). With all three orders, kindred 2755 gave an LOD score of >4.5; the maximum occurred at 0=0 with respect to probe HHH160. Linkage in this region remained indeterminate for kindred 2002, which gave a maximum LOD score of 0.98 in a multilocus analysis. The other three kindreds failed to give significant positive LOD scores for any of the three markers. Because the LOD scores across this entire region were not consistently . -2.0, statistical exclusion of the disease gene from the entire region could not be made in these three kindreds. However, the location scores for the three anonymous chromosome 14 (Table 5 ). The myosin markers MYOB-2124 and MYOB-16 were used in a linkage analysis of the disease as it segregated in kindred 2755 but were uninformative. These and another marker, MYOB-X3, were more helpful in the analysis of the four other kindreds. In three, the disease gene was shown not to map to the 83-MHC gene locus. In the fourth kindred, there was some evidence of disease linkage to the locus. for nonallelic genetic heterogeneity. Some individuals in both families had very thickened hearts and exhibited obstructive disease. The incidence of sudden death was also relatively low in affected members of both families (Figure 1) 
